---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-026121"
form_type: "8-K"
ticker: "LFMD"
cik: "0000948320"
company_name: "LifeMD, Inc."
filed_at: "2023-07-31T23:59:59+00:00"
generated_at: "2026-06-12T22:44:59.049885+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# LifeMD President Alex Mironov resigns to join Rothschild & Co.

## Summary
- Alex Mironov voluntarily resigned as President of LifeMD, effective July 28, 2023.
- Mr. Mironov is leaving to become a Managing Director at Rothschild & Co.
- Resignation was not due to any disagreement with LifeMD on operations, policies, or practices.
- No successor has been named; the company thanked him for his service.

## SEC filing metadata
- accession: 0001493152-23-026121
- form_type: 8-K
- ticker: LFMD
- cik: 0000948320
- company_name: LifeMD, Inc.
- filed_at: 2023-07-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/948320/000149315223026121/0001493152-23-026121-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/948320/000149315223026121/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-026121
- JSON: https://secwatch.observer/filing/0001493152-23-026121.json
- Plain text: https://secwatch.observer/filing/0001493152-23-026121.txt

## Key facts
- Executive change
  Alex Mironov resigned as President at LifeMD, Inc..
  - Action: resigned
  - Role: President
  source text: On July 28, 2023, Alex Mironov voluntarily resigned from his position as President of LifeMD, Inc. (the “Company”) in connection with his appointment as a Managing Director of Rothschild & Co.
  evidence_url: https://www.sec.gov/Archives/edgar/data/948320/000149315223026121/0001493152-23-026121-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.